Theranostics

There are 4 cohorts of patient sample in this study, the discovery cohort 1 compromised of 4 NSCLC, 3 ASPS and 3 lymphoma patients, the discovery cohort 2 included 13 NSCLC, 12 ASPS and 10 lymphoma patients, there were 16 NSCLC, 12 ASPS and 46 lymphoma patients in verification cohort, the validation cohort consisted of 17 NSCLC and 43 lymphoma ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download